Neuronal and Behavioral Abnormalities in Schizophrenia Derived Cells and Animal Model are Amended by Mitochondria Transplantation

被引：0
|
作者：
Ben-Shachar, Dorit [1 ]
Ene, Hila [1 ]
Karry, Rachel [1 ]
Weiner, Ina [2 ]
机构：
[1] Technion Israel Inst Technol, Rambam Hlth Care Campus, Haifa, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
来源：
BIOLOGICAL PSYCHIATRY | 2020年 / 87卷 / 09期
基金：
以色列科学基金会;
关键词：
Schizophrenia; Mitochondria Transplantation; Prenatal poly-I:C rat model; SZ-Related Behavior; Mitochondrial Function;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [1] Clozapine and rapamycin reverse behavioral abnormalities in an animal model of autoimmune schizophrenia
    Liu, Duilin
    Zhu, Caiyun
    Wei, Hui
    NEUROPHARMACOLOGY, 2025, 266
  • [2] Clozapine attenuates mitochondrial dysfunction, inflammatory gene expression, and behavioral abnormalities in an animal model of schizophrenia
    Amiri, Shayan
    Dizaji, Rana
    Momeny, Majid
    Gauvin, Evan
    Hosseini, Mir-Jamal
    NEUROPHARMACOLOGY, 2021, 187
  • [3] Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
    Peres, Fernanda F.
    Diana, Mariana C.
    Levin, Raquel
    Suiama, Mayra A.
    Almeida, Valeria
    Vendramini, Ana M.
    Santos, Camila M.
    Zuardi, Antonio W.
    Hallak, Jaime E. C.
    Crippa, Jose A.
    Abilio, Vanessa C.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [4] Isolated Mitochondria Transfer Improves Neuronal Differentiation of Schizophrenia-Derived Induced Pluripotent Stem Cells and Rescues Deficits in a Rat Model of the Disorder
    Robicsek, Odile
    Ene, Hila M.
    Karry, Rachel
    Ytzhaki, Ofer
    Asor, Eyal
    McPhie, Donna
    Cohen, Bruce M.
    Ben-Yehuda, Rotem
    Weiner, Ina
    Ben-Shachar, Dorit
    SCHIZOPHRENIA BULLETIN, 2018, 44 (02) : 432 - 442
  • [5] Mitochondria Improve Impaired Neuronal Differentiation of Hair Follicle-derived Induced Pluripotent Stem Cells of Schizophrenia Patients
    Ben-Shachar, Dorit
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S50 - S50
  • [6] Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia
    Piontkewitz, Yael
    Arad, Michal
    Weiner, Ina
    SCHIZOPHRENIA BULLETIN, 2011, 37 (06) : 1257 - 1269
  • [7] Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia
    Hadar, R.
    Bikovski, L.
    Soto-Montenegro, M. L.
    Schimke, J.
    Maier, P.
    Ewing, S.
    Voget, M.
    Wieske, F.
    Goetz, T.
    Desco, M.
    Hamani, C.
    Pascau, J.
    Weiner, I.
    Winter, C.
    MOLECULAR PSYCHIATRY, 2018, 23 (04) : 943 - 951
  • [8] Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia
    R Hadar
    L Bikovski
    M L Soto-Montenegro
    J Schimke
    P Maier
    S Ewing
    M Voget
    F Wieske
    T Götz
    M Desco
    C Hamani
    J Pascau
    I Weiner
    C Winter
    Molecular Psychiatry, 2018, 23 : 943 - 951
  • [9] Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
    Stark, Tibor
    Ruda-Kucerova, Jana
    Iannotti, Fabio Arturo
    D'Addario, Claudio
    Di Marco, Roberta
    Pekarik, Vladimir
    Drazanova, Eva
    Piscitelli, Fabiana
    Bari, Monica
    Babinska, Zuzana
    Giurdanella, Giovanni
    Di Bartolomeo, Martina
    Salomone, Salvatore
    Sulcova, Alexandra
    Maccarrone, Mauro
    Wotjak, Carsten T.
    Starcuk, Zenon, Jr.
    Drago, Filippo
    Mechoulam, Raphael
    Di Marzo, Vincenzo
    Micale, Vincenzo
    NEUROPHARMACOLOGY, 2019, 146 : 212 - 221
  • [10] Behavioral and neurochemical abnormalities in heterozygous Reelin Orleans mutant mouse model of schizophrenia
    Yamada, Kiyofumi
    Sobue, Akira
    Aoyama, Yuki
    Wei, Shan
    Nagai, Taku
    Aleksic, Branko
    Kushima, Itaru
    Ozaki, Norio
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 185 - 185
12345